PDX Portal

Model Details

Patient Information for Model: TCCC-OS63

Model Contact

Model: TCCC-OS63
Model Contact: Nino Rainusso
Institution: TCH Sarcoma PDX Program
Email: ncrainuss@texaschildrens.org

Patient Information

Clinical Timeline

Clinical Information at Collection

Clinical Biomarkers/Mutations

Pathology Information at Collection

Model Information for Model: TCCC-OS63

Model Details - Initial Implantation of Patient Tissue

Mutations (Cancer Gene Census List)

Mutation data is currently not available.

CNV

There are no omics data for this model.

Histology Information for Model: TCCC-OS63

There are no histology images for this model.

Metastasis Information for Model: TCCC-OS63

Patient

PDX

Bone

Lung

Patient Treatment Information for Model: TCCC-OS63

Event Id	Treatment	Treatment Setting	Age at Start	Age at End	Duration	Clinical Response	Pathologic Response	Reason Stopped
10	Methotrexate, Doxorubicin, Cisplatin	Neoadjuvant	10.66	11.0	124 days	Partial response	Poor response (5% tumor necrosis); progressed on neoadjuvant chemotherapy	Surgical resection (local control)
20	Ifosfamide /Etoposide	Adjuvant	11.08	11.25	62 days	Partial response		Metastectomy (surgical resection lung metastasis)
30	Ifosfamide /Etoposide	Adjuvant	11.33	11.66	120 days	Progress on chemotherapy		Progression of disease ,died